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The Journal of Cystic Fibrosis: A success storyIn its fourth year of existence the Journal of Cystic Fibrosis,
the official journal of the European Cystic Fibrosis Society, is
perfectly healthy and steadily growing. Looking back, its
founding was not as easy as one would guess today. The first
ideas to found a journal, dedicated entirely to the hereditary
disease cystic fibrosis, were not positively received by
everybody in the field. Nevertheless, initiatives started soon
after the foundation of the Society in 1998. After negotiations
with various publishers in Europe and North America for 3
years, a mutually beneficial agreement was achieved with
Elsevier Science. After the official announcement of the
Journal at the 2001 European Cystic Fibrosis Conference in
Vienna, Austria, the first manuscripts were submitted.
It is to those colleagues who submitted manuscripts for
publication in the Journal during the first years that I would
like to express my sincere thanks. We are all aware that
Impact factors are important for our careers and clearly the
Journal has no impact factor yet. Nevertheless, I received
many high-standard manuscripts which ensured the positive
development of the Journal in this period. Likewise, the
editorial board has played a pivotal role in this context, as a
journal is only as good as its editorial board. In ensuring a
high quality of accepted manuscripts, it contributed to the
success story of the Journal and I am certain that the Journal
will obtain very soon for the first time an Impact Factor. As
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Table
Correlation between the number of submitted manuscripts and the number
of published articles in the Journal of Cystic Fibrosis between 2001 and
2005
Year Submissions Articles
2001 20 17
2002 76 36
2003 70 40
2004 65 29
2005 116 30 (32 in review, 44 rejected, 10 in revision)to maintain a high quality standard, although limited space
in the volume was not a major argument, has put me
personally sometimes in a regrettable position. The bquality
over quantityQ policy (table), however, paid off and the
Journal was accepted for Medline in spring 2004. Informa-
tion from Elsevier Science reveals that the Journal was one
of the youngest journals ever accepted for Medline at the
first application. Consequently, significantly more manu-
scripts were submitted in 2005 to the Journal compared to
previous years and it is expected that in 2007 at least 6
issues per year will appear. Progress was also made
concerning the handling of submitted manuscripts: in
January 2005 a web-based electronic submission system
was launched which enables the editorial board to work
more efficiently and guarantee a final response to the
authors within 6 weeks of submission.
The edition of six issues per year and the insurance of
high quality papers leading to an Impact Factor for the
Journal will require a lot of work and ambition from the new
Editor-in-Chief. It is therefore a pleasure to announce that
the board of the European Cystic Fibrosis Society has
appointed Gerd Dfring as the new Editor-in-Chief of the
Journal. I am convinced that in 2006 when he will step
down as president he will use all his talents and efforts to
meet the challenges that lie ahead for the Journal.
In summary, it was a pleasure for me to serve the
European Cystic Fibrosis Society as Editor-in-Chief for its
Journal from the very beginning. I am confident that it will
have a great future!
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